In a recent interview at the SNMMI conference, David Gauden, D.Phil, discussed key findings from new research evaluating the use of the PET radiotracer 18F-flotufolastat in patients with primary prostate cancer (PCa) and men with biochemical recurrence of PCa.
In an interview at the SNMMI 2024 conference, Oliver Sartor, M.D. discussed key findings from new award-winning research evaluating the potential of Pluvicto in treating patients with taxane-naïve metastatic castration-resistant prostate cancer (mCRPC).
In a recent interview, Cathy Cutler, Ph.D., shared her perspective on a number of topics affecting nuclear medicine, ranging from isotope availability and reimbursement challenges for diagnostic radiopharmaceuticals to increasing patient interest in PET imaging.
In a recent interview, Stacy Smith-Foley, M.D., shared her perspective on the shortcomings of the recently issued breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
In a recent interview, Steven Raman, M.D., discussed the use of MRI-guided transurethral ultrasound (TULSA) in the treatment of intermediate risk prostate cancer and key research findings with one- and five-year outcomes.
Discussing findings from a new study presented at the Society for Breast Imaging (SBI) conference, Shahrzad Tavana, M.D., detailed the significant impact of training sessions for MRI technologists in improving breast positioning, optimal field of view and accuracy of sequence submissions to PACS for breast MRI exams.
In a recent interview, Atul Gupta, M.D. discussed the evolution and potential impact of Fiber Optic RealShape (FORS) technology, which uses light instead of radiation to facilitate real-time 3D imaging that may lead to significant efficiencies with complex aortic procedures.
In a recent interview, Markus Scherer, M.D., discussed emerging research, presented at the American College of Cardiology Cardiovascular Summit, which showed that coronary computed tomography angiography (CTA) was associated with a significantly higher likelihood of revascularization in comparison to other modalities or direct referral for invasive coronary angiography.
In a recent interview, Eric Secemsky, M.D., discussed an array of benefits for the use of intravascular ultrasound (IVUS) in supplementing angiography for peripheral vascular interventions, current barriers preventing more widespread adoption of the technology and other salient insights from a recent multidisciplinary roundtable discussion.
In a recent interview, Alexander Rau, M.D., discussed emerging research, presented at the recent RSNA conference, that shows the capability of diffusion microstructural imaging to differentiate subtle shifts in microstructural gray matter associated with common symptomatology of long Covid.
In an interview at the recent RSNA conference, Catherine Everett, M.D., shared her perspective on the radiology workforce shortage, offered insights on recruiting radiologists to rural areas and emphasized the urgency of bolstering access to radiologists and other health-care professionals for at-risk communities.
In a recent interview, Mahsa Dolatshahi, M.D., M.P.H., and Cyrus A. Raji, M.D., Ph.D., discussed MRI and PET study findings, presented at the Radiological Society of North America (RSNA) conference, that showed an association between higher amyloid PET tracer uptake in the precuneus cortex and a higher visceral to subcutaneous fat ratio.
In a recent interview at the annual RSNA conference in Chicago, Richard Heller, MD discussed the impact of reduced reimbursement rates in radiology, the projected CMS conversion factor for 2024, the severity of payment cuts in interventional radiology and the importance of radiologist advocacy.
Dr. Kottler sat down with Diagnostic Imaging at RSNA 2023 to discuss AI imaging milestones and the potential impact of AI on workflows in radiology.
In a recent interview about President Biden’s recent executive order on artificial intelligence (AI), Morris Panner, the president of Intelerad Medical Systems, shared his concerns that the executive order, while well-intentioned, may wind up stifling innovation and the continued evolution of AI in radiology.
Radiology experts discuss the current knowledge and use of PSMA-PET screening among colleagues, as well as unmet needs.
Imaging experts compare gallium-based agents to non–gallium-based agents for prostate cancer screening.
Experts highlight gallium-based and PyL PSMA-PET scans for use in prostate cancer, commenting on approvals as well as how the agents are made.
Two experts review SNMMI (Society of Nuclear Medicine and Molecular Imaging) guidelines for use of PSMA PET scans in prostate cancer detection, as well as awareness about this new modality within the patient community.
Experts highlight the use of PSMA PET scans as a recent and accurate imaging method for prostate cancer screening.
Imaging experts discuss the challenges with traditional imaging modalities for prostate cancer, commenting on the bone scan and CT scan.
Experts review traditional imaging modalities for prostate cancer, highlighting the most commonly used modalities.
In a recent video interview, Vivek Bansal, M.D., discussed a recent Radiology Partners publication that offers practical tips and best practice guidance on CT and MRI neuroimaging for stroke patients.
Joseph Cavallo, MD, MBA, and Dushyant Sahani, MD, discuss unmet needs in imaging modality technology and the contrasting agents used.
Experts discuss discuss the American College of Radiology recommendations regarding the use of contrast media and their guidance related to the use of generics during supply shortages.
Joseph Cavallo, MD, MBA, and Dushyant Sahani, MD, discuss generic agents iodixanol injection and gadoterate meglumine injection for the use in imaging modalities.
Experts discuss the concept of generics and how they have traditionally been utilized in the healthcare space.
Joseph Cavallo, MD, MBA, and Dushyant Sahani, MD, provide an overview of the different imaging technique protocols needed for contrast agents.
In interviews at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference, researchers discussed the potential impact of ultra-high resolution brain positron emission tomography (PET) as well as emerging PET radiotracers for detecting coronary artery disease in obese patients and diagnosing clear cell renal cell carcinoma.
Radiology experts discuss the role of contrast agents in imaging and the impact these agents have on image quality.
